Overview
Papillary Thyroid Cancer (PTC) is the most common malignancy of the thyroid gland, a well-differentiated carcinoma arising from follicular epithelial cells and characterized histologically by distinctive papillary architecture, overlapping ground-glass ("Orphan Annie eye") nuclei, nuclear grooves, and psammoma bodies. It typically grows slowly, has a marked tendency toward lymphatic spread to regional cervical nodes, and generally carries a favorable prognosis. Diagnosis relies on ultrasonography, fine-needle aspiration cytology, and increasingly on molecular characterization of driver alterations such as BRAF and RAS mutations and RET rearrangements, which refine risk stratification and inform management. Because PTC retains features of normal thyroid biology, including iodine avidity and dependence on transcription factors governing thyroid-cell proliferation, treatment is built around total or partial thyroidectomy followed, in selected cases, by radioactive iodine ablation and thyroid-stimulating-hormone-suppressive therapy, with long-term surveillance using thyroglobulin and imaging. The articles assembled here address Thyroid Cancer diagnosis and molecular workup, surgical and radioiodine treatment outcomes over extended follow-up, incidence trends in defined populations, image-guided ablation, the role of thyroid transcription factor-1 in tumor-cell proliferation, and trace-element composition of malignant nodules, together reflecting the diagnostic, molecular, surgical, and radioisotopic dimensions central to managing differentiated thyroid carcinoma.
Research published in this journal
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Secular Trend in the Incidence of Japanese Employees with Thyroid Cancer Undergoing Thyroidectomy from 2005 to 2014: a Retrospective Descriptive Study Using an Employment-Based Insurance Claims Database
Primary Leiomyosarcoma of the Thyroid; a Case Report and a Review of Recent Literature
Outcomes of Differentiated Thyroid Cancer Patients Treated with Surgery and Radioactive Iodine at SQCCCRC
Evaluation of Household Radiation Exposure and Safety after Ambulatory Radioiodine Ablation Therapy
Image Guided Ablations for Thyroid Tumours
Thyroid Transcription Factor-1 Activity is Required for the Proliferation of Human Thyroid Cancer Cells 8505C
In The Pursuit of The Perfect Thyroid Care
Content of Copper, Iron, Iodine, Rubidium, Strontium and Zinc in Thyroid Malignant Nodules and Thyroid Tissue adjacent to Nodules
How this research is being cited
The 10 articles above have been cited 21 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine2026 · Pharmaceutics
-
2024 · Food Analytical Methods
-
2024 · Food Analytical Methods
-
2022 · Cancers
-
2022 · World Journal of Advanced Research and Reviews
-
2022 · Saudi Journal of Biomedical Research
-
2022 · Universal Journal of Pharmaceutical Research
-
2022 ·
A sample of recent works citing this journal's research on Papillary Thyroid Cancer, linking to each citing work.